A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1992
12/21/1992	CA2071398A1 Aminomethyl-substituted 2,3-dihydropyrano/2,3-b/pyridines, process for their preparation and their use in medicaments
12/17/1992	DE4119758A1 Aminoalkylsubstituierte 2-amino-5-mercaptothiadiazole, ihre herstellung und verwendung Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and use
12/17/1992	DE4119755A1 Aminoalkylsubstituierte 2-amino-1,3,4-thiadiazole, ihre herstellung und verwendung Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, their preparation and use
12/16/1992	EP0518819A2 Amidino compounds, their manufacture and use as medicament
12/16/1992	EP0518818A2 Arylethers, their manufacture and use as medicament
12/16/1992	EP0518798A2 Compositions for use in the treatment of aphtous ulcers and other mucocutaneous disorders
12/16/1992	EP0518769A1 Ethanolaminebenzoate derivative, process for their preparation and pharmaceutical compositions containing them
12/16/1992	EP0518731A1 Heterocyclic derivatives of substituted 2-acylamino 5-thiazole, their preparation and pharmaceutical compositions containing them
12/16/1992	EP0518722A1 Dithiane substituted retinoides, their use, process of their preparation, cosmetic and pharmaceutical compositions containing them and their use in therapeutics
12/16/1992	EP0518697A2 Collagen film for sustained delivery of proteins
12/16/1992	EP0518676A2 Cyclic renin inhibitors
12/16/1992	EP0518675A2 Cyclic renin inhibitors
12/16/1992	EP0518672A2 Cyclic renin inhibitors
12/16/1992	EP0518600A1 Non-chlorofluorocarbon aerosol formulations
12/16/1992	EP0518468A1 Melatonin containing compositions
12/16/1992	EP0518426A1 Thiopyrano (2,3,4-c,d) indoles as inhibitors of leukotriene biosynthesis
12/16/1992	EP0518118A1 7-Oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
12/16/1992	EP0517986A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
12/16/1992	EP0517925A1 Novel megakaryocyte amplifier and production thereof
12/16/1992	EP0517852A1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
12/16/1992	EP0517836A1 Method and product for promoting hair growth and treating skin conditions
12/16/1992	EP0517812A1 Angiotensin ii antagonists incorporating a substituted benzyl element
12/16/1992	EP0517789A1 Inhibitor of proliferation of endothelial cells.
12/16/1992	CN1067057A Process for preparing unsaturated 17 -substituted 3-carboxysteroids
12/16/1992	CN1067052A Substituted diaminophthalimides and analogues
12/16/1992	CN1019451B Cycioalkyliamides of (8beta)-1-alkyl-6-(substituted) ergolines
12/15/1992	WO1992022306A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
12/15/1992	WO1992022304A1 Collagen film drug delivery for proteins
12/15/1992	US5171670 Recombinant dna method for production of parathyroid hormone
12/15/1992	US5171579 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
12/15/1992	US5171574 Bone collagen matrix for implants
12/15/1992	US5171567 Method for the treatment of atll and the inhalant for the same
12/15/1992	US5170567 Electronic inclinometer
12/15/1992	CA2102619A1 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
12/15/1992	CA2089487A1 Collagen film drug delivery for proteins
12/15/1992	CA2071143A1 Squalene synthetase inhibitors and processes therefrom
12/15/1992	CA1311487C Derivatives of 1-benzyl-2-oxo-5-alcoxypyrrolidine, a process for their preparation and compositions containing them
12/15/1992	CA1311420C Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
12/14/1992	CA2070953A1 Thiopyrano (2,3,4-c,d) indoles as inhibitors of leukotriene biosynthesis
12/13/1992	CA2070895A1 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
12/12/1992	CA2070983A1 Cyclic renin inhibitors
12/12/1992	CA2070978A1 Cyclic renin inhibitors
12/12/1992	CA2070972A1 Cyclic renin inhibitors
12/12/1992	CA2070796A1 Arylethers, their manufacture and methods of treatment
12/12/1992	CA2070795A1 Amidino compounds, their manufacture and methods of treatment
12/11/1992	WO1992022321A1 Hepatocyte growth stimulation with hepatocyte growth factor and gamma-interferon
12/11/1992	CA2109434A1 Hepatocyte growth stimulation with hepatocyte growth factor and gamma-interferon
12/10/1992	WO1992021750A1 Eukaryotic expression vectors with regulation of rna processing
12/10/1992	WO1992021695A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992	WO1992021367A1 T cell receptor peptides as therapeutics for immune-related disease
12/10/1992	WO1992021365A1 Therapeutic compositions for osteoinduction
12/10/1992	WO1992021360A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/10/1992	WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
12/10/1992	WO1992021353A1 Compositions and delivery systems for transdermal administration of neutral oligomers
12/10/1992	WO1992021338A1 Medetomidine preparations for transdermal administration
12/10/1992	WO1992019617A3 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
12/10/1992	CA2110158A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992	CA2110040A1 Compositions and delivery systems for transdermal administration of neutral oligomers
12/10/1992	CA2109579A1 Eukaryotic expression vectors with regulation of rna processing
12/10/1992	CA2102890A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/09/1992	EP0517425A1 Fatty acids for the reduction of urinary calcium excretion and the treatment of osteoporosis
12/09/1992	EP0517394A1 A prophylactic/therapeutic composition for swine pleuropneumonia
12/09/1992	EP0517357A1 Angiotensin II antagonists incorporating a substituted indole or dihydroindole
12/09/1992	EP0517347A1 New combinations for the treatment of Parkinsons disease, containing NMDA-antagonists
12/09/1992	EP0517125A1 Use of propionyl L-carnitine for regaining muscle tone in immobilised patients
12/09/1992	EP0517047A1 Unsaturated 17beta-substituted 3-carboxy steroids
12/09/1992	CN1066847A Angiotensin ii receptor blocking 2,3,6 substituted quinazolinones
12/09/1992	CN1066781A Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta-adrenergic antagonist
12/08/1992	US5169868 Antidepressants, enzyme inhibitors; alleviating parkinsonism, alzheimer's disease
12/08/1992	US5169864 Sterile aqueous formulation of histamine H2 antagonist for antiulcer; storage stability
12/08/1992	US5169856 Cholinesterase antagonists
12/08/1992	US5169854 N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity
12/08/1992	US5169640 Pharmaceutical compositions
12/06/1992	WO1992021369A1 Synthetic calcitonin peptides
12/06/1992	CA2088922A1 Synthetic calcitonin peptides
12/06/1992	CA2070526A1 Heterocyclic substituted 2-acylamino-5-thiazoles, their preparation and pharmaceutical compositions containing them
12/06/1992	CA2070494A1 Combination preparations for treatment of parkinson's disease
12/06/1992	CA2070468A1 Fatty acid treatment
12/06/1992	CA2065078A1 Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
12/02/1992	EP0516594A1 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis
12/02/1992	EP0516588A1 Substituted diaminophtalimides and analogues
12/02/1992	EP0516530A1 New 6-substituted steroids with a thioethyl group in the 10 position, a process for their preparation and intermediates therefor, their use as medicines and pharmaceutical compositions thereof
12/02/1992	EP0516392A2 Naphthyridine derivatives as angiotensin II inhibitors
12/02/1992	EP0516194A2 Pharmaceutical compositions containing cationic surfactants
12/02/1992	EP0516069A1 Leukotriene B4 antagonist
12/02/1992	EP0515569A1 Calcium channel compositions and methods
12/02/1992	EP0515550A1 Heparin neutralization with platelet factor 4
12/02/1992	EP0515548A1 Imidazole angiotensin ii antagonists incorporating a substituted benzyl element
12/02/1992	EP0515546A1 Triazole angiotensin ii antagonists incorporating a substituted benzyl element
12/02/1992	EP0515535A1 Angiotensin ii antagonists incorporating a substituted benzyl element
12/02/1992	EP0515514A1 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
12/02/1992	EP0515510A1 Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them.
12/02/1992	EP0515394A1 COVALENT ANGIOGENIN/RNase HYBRIDS
12/02/1992	EP0496833A4 Biosynthetic constructs of tgf--g(b)
12/02/1992	CN1066654A Benzofuran derivatives
12/01/1992	WO1992021677A1 bibNUCLIDINE DERIVATIVES
12/01/1992	US5167958 Culture products of Streptomyces resistomycificus
12/01/1992	CA2069857A1 Substituted diaminophthalimides and analogues
12/01/1992	CA2069667A1 Leukotriene b4 antagonist
12/01/1992	CA2068946A1 Heterocyclic derivatives

1 ... 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 ... 1564